COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,261 | -88.9% | 62,904 | -87.3% | 0.00% | -100.0% |
| Q2 2023 | $2,116,311 | +312.1% | 495,623 | +560.2% | 0.00% | +200.0% |
| Q1 2023 | $513,527 | -19.1% | 75,077 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $634,424 | -77.8% | 80,104 | -73.0% | 0.00% | -75.0% |
| Q3 2022 | $2,855,275 | +30.7% | 297,115 | -1.5% | 0.00% | -33.3% |
| Q2 2022 | $2,184,000 | +134.6% | 301,589 | +318.0% | 0.01% | +200.0% |
| Q1 2022 | $931,000 | -14.0% | 72,142 | +6.5% | 0.00% | 0.0% |
| Q4 2021 | $1,082,000 | -3.4% | 67,760 | -2.8% | 0.00% | 0.0% |
| Q3 2021 | $1,120,000 | +18.4% | 69,710 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $946,000 | -4.3% | 68,363 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $989,000 | +20.3% | 67,722 | +43.2% | 0.00% | 0.0% |
| Q4 2020 | $822,000 | +27.2% | 47,280 | +34.3% | 0.00% | +100.0% |
| Q3 2020 | $646,000 | +1.9% | 35,211 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $634,000 | -14.3% | 35,493 | -22.3% | 0.00% | -50.0% |
| Q1 2020 | $740,000 | -8.4% | 45,651 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $808,000 | +64.9% | 44,866 | +85.7% | 0.00% | +100.0% |
| Q3 2019 | $490,000 | -8.2% | 24,165 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $534,000 | +84.1% | 24,165 | +13.8% | 0.00% | 0.0% |
| Q1 2019 | $290,000 | +44.3% | 21,230 | -4.4% | 0.00% | – |
| Q4 2018 | $201,000 | -39.1% | 22,212 | +11.1% | 0.00% | -100.0% |
| Q3 2018 | $330,000 | +26.9% | 19,992 | +7.7% | 0.00% | 0.0% |
| Q2 2018 | $260,000 | +33.3% | 18,565 | +5.4% | 0.00% | – |
| Q1 2018 | $195,000 | +25.8% | 17,607 | 0.0% | 0.00% | – |
| Q4 2017 | $155,000 | -34.0% | 17,607 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $235,000 | -7.1% | 17,607 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $253,000 | -10.3% | 17,607 | +32.2% | 0.00% | 0.0% |
| Q1 2017 | $282,000 | -24.8% | 13,314 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $375,000 | +5.0% | 13,314 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $357,000 | +58.7% | 13,314 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $225,000 | +7.1% | 13,314 | +45.9% | 0.00% | 0.0% |
| Q4 2015 | $210,000 | -35.8% | 9,128 | -19.4% | 0.00% | 0.0% |
| Q2 2015 | $327,000 | – | 11,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |